Scancell announces UK regulatory approval to start SCIB1 Phase 2 trial in patients with advanced melanoma To download click here Thursday 25 April 2019 13:00 Categories: News Regulatory News SCIB1 Year - 2019
Scancell Holdings wins Japanese patent protection It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia [View article] Monday 8 April 2019 13:20 Categories: Immunobody Media Coverage SCIB1 SCIB2 Year - 2019
Scancell announces grant of Japanese patent that protects its Moditope immunotherapy programme To download click here Monday 8 April 2019 13:00 Categories: Moditope News Regulatory News Year - 2019
Professor Lindy Durrant receives Waldenström award from the Swedish Society of Oncology To download click here Thursday 21 March 2019 12:00 Categories: Moditope News Year - 2019
IP Portfolio Strengthened To download click here Wednesday 20 March 2019 12:00 Categories: Modi-1 Moditope News Regulatory News Year - 2019
Scancell strengthens IP with two “important” patent grants in US and Europe The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88 [View article] Wednesday 20 March 2019 11:55 Categories: Media Coverage Modi-1 Moditope Year - 2019
Holdings in Company To download click here Wednesday 6 March 2019 13:00 Categories: News Regulatory News Year - 2019
Change of Auditor To download click here Thursday 21 February 2019 13:00 Categories: News Regulatory News Year - 2019
Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise [View article] Tuesday 12 February 2019 20:07 Categories: Immunobody Media Coverage Modi-1 Modi-2 SCIB1 SCIB2 Year - 2019
Scancell lauds another six months of progress The funds raised in the last year "will allow us to focus on initiating the planned Phase 2 clinical trial for our lead ImmunoBody, SCIB1, and to advance our Moditope products, Modi-1 and Modi-2, towards the clinic". [View article] Thursday 31 January 2019 13:41 Categories: Immunobody Media Coverage Modi-1 Modi-2 Moditope SCIB1 Year - 2019